Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1311 | 8520 | 33.5 | 66% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PROSTAGLANDIN D 2 | authKW | 222785 | 2% | 40% | 154 |
2 | CRTH2 | authKW | 217006 | 1% | 77% | 79 |
3 | MOL BEHAV BIOL | address | 211441 | 1% | 48% | 122 |
4 | MPGES 1 | authKW | 167166 | 1% | 61% | 77 |
5 | THROMBOXANE A2 RECEPTOR | authKW | 162378 | 1% | 68% | 67 |
6 | THROMBOXANE A2 | authKW | 137226 | 2% | 21% | 180 |
7 | PROSTANOID RECEPTORS | authKW | 134490 | 1% | 52% | 72 |
8 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | journal | 114018 | 3% | 13% | 240 |
9 | THROMBOXANE RECEPTOR | authKW | 102994 | 1% | 55% | 52 |
10 | DP RECEPTOR | authKW | 100296 | 0% | 100% | 28 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 17280 | 28% | 0% | 2359 |
2 | Peripheral Vascular Diseases | 5490 | 8% | 0% | 691 |
3 | Biochemistry & Molecular Biology | 4772 | 23% | 0% | 1967 |
4 | Endocrinology & Metabolism | 3996 | 9% | 0% | 806 |
5 | Chemistry, Medicinal | 3723 | 7% | 0% | 587 |
6 | Cell Biology | 2346 | 10% | 0% | 885 |
7 | Hematology | 1724 | 5% | 0% | 437 |
8 | Cardiac & Cardiovascular System | 1314 | 6% | 0% | 525 |
9 | Biophysics | 986 | 5% | 0% | 426 |
10 | Medicine, Research & Experimental | 756 | 5% | 0% | 401 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL BEHAV BIOL | 211441 | 1% | 48% | 122 |
2 | EXPT THER EUT PHARMACOINFORMAT | 62291 | 0% | 87% | 20 |
3 | MINASE | 40445 | 1% | 22% | 52 |
4 | FUKUI | 17229 | 0% | 28% | 17 |
5 | HUMAN GENE SCI | 16963 | 0% | 22% | 22 |
6 | ADV MED DEV | 14722 | 0% | 34% | 12 |
7 | OSAKA BIOSCI | 13477 | 0% | 47% | 8 |
8 | ANGIOL VASC BIOL INFLAMMAT | 10410 | 0% | 36% | 8 |
9 | PHARMACEUT ANALYT | 9729 | 0% | 19% | 14 |
10 | BIOTECHNOL MED BIOTECHNOL | 8184 | 0% | 57% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 114018 | 3% | 13% | 240 |
2 | PROSTAGLANDINS | 85914 | 2% | 13% | 188 |
3 | PROSTAGLANDINS LEUKOTRIENES AND MEDICINE | 73280 | 2% | 15% | 134 |
4 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 59617 | 1% | 15% | 115 |
5 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 44770 | 2% | 6% | 198 |
6 | EICOSANOIDS | 21362 | 0% | 22% | 27 |
7 | PROSTAGLANDINS AND MEDICINE | 14150 | 0% | 13% | 30 |
8 | BRITISH JOURNAL OF PHARMACOLOGY | 11091 | 3% | 1% | 238 |
9 | THROMBOSIS RESEARCH | 10813 | 2% | 2% | 178 |
10 | EUROPEAN JOURNAL OF PHARMACOLOGY | 6975 | 3% | 1% | 240 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROSTAGLANDIN D 2 | 222785 | 2% | 40% | 154 | Search PROSTAGLANDIN+D+2 | Search PROSTAGLANDIN+D+2 |
2 | CRTH2 | 217006 | 1% | 77% | 79 | Search CRTH2 | Search CRTH2 |
3 | MPGES 1 | 167166 | 1% | 61% | 77 | Search MPGES+1 | Search MPGES+1 |
4 | THROMBOXANE A2 RECEPTOR | 162378 | 1% | 68% | 67 | Search THROMBOXANE+A2+RECEPTOR | Search THROMBOXANE+A2+RECEPTOR |
5 | THROMBOXANE A2 | 137226 | 2% | 21% | 180 | Search THROMBOXANE+A2 | Search THROMBOXANE+A2 |
6 | PROSTANOID RECEPTORS | 134490 | 1% | 52% | 72 | Search PROSTANOID+RECEPTORS | Search PROSTANOID+RECEPTORS |
7 | THROMBOXANE RECEPTOR | 102994 | 1% | 55% | 52 | Search THROMBOXANE+RECEPTOR | Search THROMBOXANE+RECEPTOR |
8 | DP RECEPTOR | 100296 | 0% | 100% | 28 | Search DP+RECEPTOR | Search DP+RECEPTOR |
9 | PGD2 | 92554 | 1% | 47% | 55 | Search PGD2 | Search PGD2 |
10 | PROSTAGLANDINS | 88069 | 5% | 6% | 430 | Search PROSTAGLANDINS | Search PROSTAGLANDINS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WOODWARD, DF , JONES, RL , NARUMIYA, S , (2011) INTERNATIONAL UNION OF BASIC AND CLINICAL PHARMACOLOGY. LXXXIII: CLASSIFICATION OF PROSTANOID RECEPTORS, UPDATING 15 YEARS OF PROGRESS.PHARMACOLOGICAL REVIEWS. VOL. 63. ISSUE 3. P. 471 -538 | 477 | 53% | 146 |
2 | JONES, RL , GIEMBYCZ, MA , WOODWARD, DF , (2009) PROSTANOID RECEPTOR ANTAGONISTS: DEVELOPMENT STRATEGIES AND THERAPEUTIC APPLICATIONS.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 158. ISSUE 1. P. 104 -145 | 274 | 65% | 84 |
3 | NARUMIYA, S , SUGIMOTO, Y , USHIKUBI, F , (1999) PROSTANOID RECEPTORS: STRUCTURES, PROPERTIES, AND FUNCTIONS.PHYSIOLOGICAL REVIEWS. VOL. 79. ISSUE 4. P. 1193 -1226 | 137 | 62% | 1593 |
4 | HATA, AN , BREYER, RM , (2004) PHARMACOLOGY AND SIGNALING OF PROSTAGLANDIN RECEPTORS: MULTIPLE ROLES IN INFLAMMATION AND IMMUNE MODULATION.PHARMACOLOGY & THERAPEUTICS. VOL. 103. ISSUE 2. P. 147-166 | 154 | 72% | 426 |
5 | NAKAHATA, N , (2008) THROMBOXANE A(2): PHYSIOLOGY/PATHOPHYSIOLOGY, CELLULAR SIGNAL TRANSDUCTION AND PHARMACOLOGY.PHARMACOLOGY & THERAPEUTICS. VOL. 118. ISSUE 1. P. 18-35 | 141 | 73% | 164 |
6 | BREYER, RM , BAGDASSARIAN, CK , MYERS, SA , BREYER, MD , (2001) PROSTANOID RECEPTORS: SUBTYPES AND SIGNALING.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. VOL. 41. ISSUE . P. 661 -690 | 113 | 80% | 608 |
7 | HIRATA, T , NARUMIYA, S , (2011) PROSTANOID RECEPTORS.CHEMICAL REVIEWS. VOL. 111. ISSUE 10. P. 6209 -6230 | 153 | 68% | 27 |
8 | COLEMAN, RA , SMITH, WL , NARUMIYA, S , (1994) INTERNATIONAL UNION OF PHARMACOLOGY CLASSIFICATION OF PROSTANOID RECEPTORS - PROPERTIES, DISTRIBUTION, AND STRUCTURE OF THE RECEPTORS AND THEIR SUBTYPES.PHARMACOLOGICAL REVIEWS. VOL. 46. ISSUE 2. P. 205 -229 | 102 | 73% | 1468 |
9 | FITZGERALD, GA , RICCIOTTI, E , (2011) PROSTAGLANDINS AND INFLAMMATION.ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. VOL. 31. ISSUE 5. P. 986 -1000 | 92 | 53% | 464 |
10 | CHEN, YQ , LIU, HQ , XU, S , WANG, TL , LI, W , (2015) TARGETING MICROSOMAL PROSTAGLANDIN E-2 SYNTHASE-1 (MPGES-1): THE DEVELOPMENT OF INHIBITORS AS AN ALTERNATIVE TO NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS).MEDCHEMCOMM. VOL. 6. ISSUE 12. P. 2081 -2123 | 127 | 71% | 1 |
Classes with closest relation at Level 2 |